TickerGuard
Buy Day today: Poor (42) Weak market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.427$ -10.0% vs. previous close Closing price · As of: Nov 20, 2026

Statements

Income Statement

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 81 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Income Statement CGC
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 LTM
79 73 66 63 75 65 72 67 102 71 81 81 336
50 57 43 41 51 54 54 45 73 63 59 58 253
28 15 23 22 24 11 18 22 29 8.3 22 23 83
1.3 0.8 – – – 2.7 – – – – – – –
28 24 23 22 22 6.4 15 16 19 15 34 36 104
89 122 52 68 48 15 41 39 66 36 44 46 192
-60 -107 -29 -46 -24 -4.4 -23 -17 -36 -27 -22 -23 -109
25 21 21 21 17 15 9.7 8.8 10 12 13 13 48
-231 -96 -123 -131 -122 -221 -41 -1.4 -85 -158 -15 -41 -300
-1.1 -1.4 6.2 0.3 0.3 0.3 0.3 0.2 0.5 -0.9 -0.1 -0.8 -1.3
-217 -92 -127 -128 -122 -221 -42 -1.6 -86 -157 -15 -41 -298
-194 -64 -91 -100 -95 -194 -22 17 -66 -137 -4.7 -28 -237

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?